Examination Report |
1 | TM-1 | 14 Jul 2016 |
10 | Annexure -1 under rule 46 | 18 Jan 2022 |
10 | Evidence Affidavit Under Rule 46 (TOP) | 18 Jan 2022 |
2 | General Power of Attorney | 22 Nov 2016 |
3 | General Power of Attorney | 23 Nov 2016 |
4 | Reply to Exam Report (MIS-R) | 09 Jun 2017 |
5 | Journal Copy | 17 May 2019 |
6 | TM-O(NOTICE OF OPPOSITION) | 24 Jun 2019 |
7 | Annexure -1 under rule 46 | 16 Nov 2021 |
7 | Evidence Affidavit Under Rule 46 (TOP) | 16 Nov 2021 |
8 | Annexure -1 under rule 46 | 16 Nov 2021 |
8 | Evidence Affidavit Under Rule 46 (TOP) | 16 Nov 2021 |
9 | Annexure -1 under rule 46 | 18 Jan 2022 |
9 | Evidence Affidavit Under Rule 46 (TOP) | 18 Jan 2022 |
1 | Application(3308850) Keep Pending | 4169803 | 1953173 | 02 Nov 2016 |
2 | Hearing Notice (Show Cause) | 7075031 | 3261273 | 01 Oct 2018 |
3 | Hearing notice (Adjourned) | 7560063 | 3648711 | 03 Jan 2019 |
4 | Tribunal Accepted Notice for : 3308850 | 7770473 | 3761916 | 11 Feb 2019 |
5 | Opposition Notice | 8707652 | 4302185 | 02 Aug 2019 |
6 | Opposition Counter Statement | 9317732 | 4573288 | 28 Nov 2019 |
The application for Reblat dsr (label) was made on 14 July 2016.
The trademark applicant for Reblat dsr (label) is RELIABO PHARMA INDIA.
Reblat dsr (label) is applied in class(es) 5.
Application for Reblat dsr (label) is on Opposed stage.
Application Id allotted to Reblat dsr (label) is 3308850.
Trademark agent or attorney for the application is D. Sen & Co.
Reblat dsr (label) filed with the Intellectual property office as a DEVICE.